STOCKS IN FOCUS (22nd Oct 2026)

STOCKS IN NEWS

• Nestlé India and Zydus Wellness: The Food Safety and Standards Authority of India (FSSAI) issued notices to both companies over allegedly misleading claims in certain products. The companies have been asked to submit scientific evidence supporting their advertisements.

• RBL Bank: The private sector lender is evaluating a potential entry into the broking and asset management businesses as part of its strategy to expand its capital market activities.

• Sanofi Healthcare: The company received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for Qfitlia, a therapy used to prevent bleeding episodes in patients with haemophilia.

• Zydus Lifesciences: The company received final approval from the US health regulator to market a generic transdermal system for treating moderate-to-severe menopausal symptoms and preventing postmenopausal osteoporosis.

• Transrail Lighting: The company secured new orders worth ₹927 crore, primarily across domestic and international markets. With these additions, its order intake for the year has increased to ₹3,356 crore.

• Bharat Electronics (BEL): The company secured additional orders worth ₹1,011 crore since its previous disclosure on October 13, 2026. The orders include improved low-level lightweight radar systems, communication equipment, sonar systems, jammers, upgrades, spares and services.

• Tata Power: The company is establishing a global capability centre (GCC) in Odisha, the first under the state’s dedicated GCC policy framework. The centre will leverage Tata Power’s operational experience and digital capabilities to develop next-generation solutions for the evolving energy sector.

• Seamec: The company entered into a contract with HAL Offshore to charter its vessel SEAMEC ANANT for inspection, maintenance and repair (IMR) activities for Oil and Natural Gas Corporation (ONGC). The charter period is approximately 1,225 days, subject to HAL Offshore’s charter agreement with ONGC. The total contract value is approximately US$55 million.

• Zydus Lifesciences: Zylidac Bio, a biologics contract development and manufacturing organisation (CDMO) within the Zydus Lifesciences group, partnered with biotechnology company Prolific Machines to scale Prolific’s platform from early-stage development through good manufacturing practice (GMP) production.

• Persistent Systems: The IT company opened its qualified institutions placement (QIP) issue on October 21, with the floor price set at ₹5,761 per share.

• Gujarat Mineral Development Corporation (GMDC): The company presented a dividend of ₹223.55 crore to the Gujarat Government. The dividend of ₹9.50 per equity share was recommended by the board on May 14 and approved by shareholders on September 30.

BULK DEALS

• HD Fire Protect: Allianz Global Investors GmbH, acting on behalf of Allianz Soa Fonds, purchased 17.55 lakh shares, representing a 1% stake in the company’s paid-up equity, for ₹55.73 crore at ₹317.48 per share.

• PC Jeweller: Investor Aditya Kumar Halwasiya acquired an additional 5.51 crore equity shares, representing a 0.56% stake in the company, for ₹101.3 crore at ₹18.39 per share.

• Rappid Valves (India): Maharashtra Defence and Aerospace Venture Fund sold 1.44 lakh shares, representing a 2.77% stake in the company’s paid-up equity, for ₹5.11 crore at ₹355.33 per share.

• Encompass Design India: Foreign portfolio investor Minerva Ventures Fund acquired 2.42 lakh shares, representing a 1.71% stake in the company, for ₹5.83 crore at ₹241 per share.

Source: Moneycontrol, Business Standard

Major Results Today:

Corporate Actions:

Disclaimer:

Investment in securities markets is subject to market risks. Please read all related documents carefully before investing. (Our SEBI Reg. No. INH000010335)

AI Usage Disclosure: Artificial Intelligence (AI) tools were utilized exclusively for document formatting, structural layout, and presentation refinement.
All underlying research, financial analysis, forecasts, and investment recommendations are fully independent and conducted solely by the analyst(s).

For Full Disclaimer: Click Here